Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521048 | SCV000617598 | pathogenic | not provided | 2019-12-24 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate that this variant results in impaired transactivation activity and structural alteration at functional domains (Perez Garrido et al., 2015); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported previously in association with severe hypospadias and variable micropenis and cryptorchidism in at least one family, affected males inherited the variant from their unaffected father (Adamovic et al., 2012); This variant is associated with the following publications: (PMID: 25160005, 23154282, 22907560, 22100173, 30425642) |
Revvity Omics, |
RCV000521048 | SCV002020160 | likely pathogenic | not provided | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002527576 | SCV003441482 | pathogenic | Oligosynaptic infertility; 46,XY disorder of sex development | 2021-12-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 313 of the NR5A1 protein (p.Arg313His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with NR5A1-related conditions (PMID: 22907560, 30425642). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 449434). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant disrupts the p.Arg313 amino acid residue in NR5A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22028768, 25122490, 27169744, 30425642). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Center for Reproductive Medicine, |
RCV001662528 | SCV001877167 | pathogenic | Genetic non-acquired premature ovarian failure | 2019-10-01 | no assertion criteria provided | research |